Market News / Story
Stryker, Abbott among Overweight ideas as Barclays turns bullish on MedTech
Seeking Alpha ·
Seeking Alpha reports: Stryker and Abbott Laboratories traded higher on Wednesday after Barclays named the stocks among its Overweight-rated large-cap MedTech names as part of a largely bullish coverage initiation on the sector. Analyst Christopher Pasquale initiated coverage of 26 medical device makers on Tuesday, noting that the recent underperformance of the MedTech space has opened an opportunity to buy high-quality names at compelling valuations. Pasquale’s bullish thesis comes at a…